Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
5,739
Total Claims
$529K
Drug Cost
922
Beneficiaries
$574
Cost/Patient
Risk Score Breakdown 51/100
Score components are additive. Read full methodology
Peer Comparison vs. 109,535 Physician Assistant providers
+619%
Opioid rate vs peers
66.1% vs 9.2% avg
-20%
Cost per patient vs peers
$574 vs $719 avg
+53%
Brand preference vs peers
10.2% vs 6.7% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
66.1%
Opioid Rate
3,793
Opioid Claims
$333K
Opioid Cost
16.7%
Long-Acting Rate
This provider's opioid prescribing rate of 66.1% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 583 claims · $357K
Generic: 5,156 claims · $172K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Tapentadol Hcl | 28 | $53K |
| Oxycodone Myristate | 62 | $39K |
| Buprenorphine Hcl | 45 | $37K |
| Naloxegol Oxalate | 81 | $36K |
| Buprenorphine | 98 | $32K |
| Oxycodone Hcl | 57 | $30K |
| Oxycodone Hcl/Acetaminophen | 857 | $29K |
| Rimegepant Sulfate | 14 | $28K |
| Tapentadol Hcl | 17 | $24K |
| Hydrocodone/Acetaminophen | 862 | $23K |
| Oxycodone Hcl | 942 | $20K |
| Ubrogepant | 12 | $20K |
| Linaclotide | 33 | $18K |
| Lidocaine | 61 | $9,584 |
| Pregabalin | 233 | $7,614 |
Prescribing Profile
39
Unique Drugs
51.0
Anomaly Score
Patient Profile
65
Avg Age
69%
Female
1.72
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About